COMMUNIQUÉS West-GlobeNewswire

Wake Radiology Adds Rad AI Technology to Revolutionize Radiology Reporting

29/07/2024 - 15:30

Powerful generative AI software will enhance diagnostic speed, precision & patient outcomes Raleigh, July 29, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, a leading provider of outpatient medical [...]

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

29/07/2024 - 15:15

OCALA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. In the CEO [...]

Hapbee Announces Closing of Non-Brokered Private Placement

29/07/2024 - 15:15

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (the “ Company ” or “ Hapbee ”) (TSX-V: HAPB) (OTCQB: HAPBF) (FSE: HA1) – The Company is pleased to announce that it has now [...]

Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call

29/07/2024 - 15:00

DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

INmune Bio Inc. Announces New Phase 1 Study Data Demonstrating Dose-Dependent Effect of XPro™ on Proteins that Regulation Synapses in Alzheimer’s Patients

29/07/2024 - 15:00

AAIC Poster Presentation Highlights XPro's™ Significant Effects on a Wide Range of Synaptic Proteins and Pathways BOCA RATON, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a [...]

Promex Industries and QP Technologies Implement Sales/Marketing Reorganization, Promoting Rosie Medina to Promex Senior Vice President and Matt Hansen to QP Technologies Vice President

29/07/2024 - 15:00

Two companies heightening focus on individual core competencies to better pursue rapidly expanding business opportunities SANTA CLARA, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Promex Industries , a Silicon Valley-based [...]

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

29/07/2024 - 15:00

SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, [...]

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)

28/07/2024 - 22:51

– Featured Research Session oral presentation highlights findings that show Lomecel-B™ improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer’s Disease – – Study meets its key [...]

Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease

28/07/2024 - 14:05

Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain barrier Data to be [...]

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

28/07/2024 - 13:30

NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers ( [...]

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

27/07/2024 - 03:25

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical [...]

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2024 Financial Results on August 1, 2024

26/07/2024 - 22:30

FREDERICK, Md., July 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]

Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024

26/07/2024 - 22:11

PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders will host an [...]

vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold

26/07/2024 - 22:05

HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, [...]

NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024

26/07/2024 - 22:01

Company to host conference call on Monday, July 29 at 8:30 a.m. ET NAARDEN, the Netherlands and MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company [...]

EssilorLuxottica: Publication of the 2024 Interim Financial Report

26/07/2024 - 18:30

Publication of the 2024 Interim Financial Report Paris, France (July 26, 2024 – 6:30 pm) – The Board of Directors of EssilorLuxottica met on July 25, 2024 to approve the condensed consolidated interim financial [...]

EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2024

26/07/2024 - 18:30

Mise à disposition du Rapport financier semestriel 2024 Paris, France (26 juillet 2024 – 18h30) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 25 juillet 2024, a arrêté les comptes consolidés [...]

eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences

26/07/2024 - 17:59

BOSTON, July 26, 2024 (GLOBE NEWSWIRE) -- eLabNext, a leading provider of digital lab management solutions, and ABI-LAB , a premier life sciences incubator located in Natick, MA, have announced a strategic alliance [...]

BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo

26/07/2024 - 17:15

July 26, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM 2024 Conference – Chicago, July 26, 2024 – BioPorto Diagnostics, a company specializing in in vitro [...]